US FDA approves use of Gilead’s remdesivir for hospitalised coronavirus patients – ABC News

The US Food and Drug Administration has approved Gilead Sciences’ antiviral drug remdesivir for treating patients hospitalised with COVID-19, making it the first and only drug approved for the disease in the United States.

• The FDA’s formal approval for remdesivir’s widespread use came hours before the final presidential debate
• However, the World Health Organization found the drug did not have a substantial effect on patients’ length of hospital stays or chances of survival
• Remdesivir will be sold…

Click here to view the original article.